These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 1835397)

  • 1. Treatment of hypercalcaemia of malignancy with clodronate.
    Bonjour JP; Rizzoli R
    Bone; 1991; 12 Suppl 1():S19-23. PubMed ID: 1835397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clodronate in hypercalcemia of malignancy.
    Bonjour JP; Rizzoli R
    Calcif Tissue Int; 1990; 46 Suppl():S20-5. PubMed ID: 2137362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clodronate. A review of its pharmacological properties and therapeutic efficacy in resorptive bone disease.
    Plosker GL; Goa KL
    Drugs; 1994 Jun; 47(6):945-82. PubMed ID: 7521833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of the hypercalcaemia of malignancy with intravenous clodronate.
    Urwin GH; Yates AJ; Gray RE; Hamdy NA; McCloskey EV; Preston FE; Greaves M; Neil FE; Kanis JA
    Bone; 1987; 8 Suppl 1():S43-51. PubMed ID: 2961354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of clodronate in multiple myeloma.
    Delmas PD
    Bone; 1991; 12 Suppl 1():S31-4. PubMed ID: 1835398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of clodronate and calcitonin in hypercalcemia due to malignancy.
    Ljunghall S
    Recent Results Cancer Res; 1989; 116():40-5. PubMed ID: 2527399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of a single infusion of alendronate in malignant hypercalcaemia: dose dependency and comparison with clodronate.
    Rizzoli R; Buchs B; Bonjour JP
    Int J Cancer; 1992 Mar; 50(5):706-12. PubMed ID: 1531972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effective treatment of malignant hypercalcaemia with a single intravenous infusion of clodronate.
    O'Rourke NP; McCloskey EV; Vasikaran S; Eyres K; Fern D; Kanis JA
    Br J Cancer; 1993 Mar; 67(3):560-3. PubMed ID: 8439504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Response to intravenous bisphosphonate therapy in hypercalcaemic patients with and without bone metastases: the role of parathyroid hormone-related protein.
    Walls J; Ratcliffe WA; Howell A; Bundred NJ
    Br J Cancer; 1994 Jul; 70(1):169-72. PubMed ID: 8018531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment with clodronate in patients with hypercalcemia secondary to malignancy.
    Lind L; Wengle B; Ljunghall S
    Ups J Med Sci; 1987; 92(3):259-63. PubMed ID: 2966487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathophysiological aspects and therapeutic approaches of tumoral osteolysis and hypercalcemia.
    Bonjour JP; Rizzoli R
    Recent Results Cancer Res; 1989; 116():29-39. PubMed ID: 2669066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomised double-blind comparison of intravenous pamidronate and clodronate in the hypercalcaemia of malignancy.
    Purohit OP; Radstone CR; Anthony C; Kanis JA; Coleman RE
    Br J Cancer; 1995 Nov; 72(5):1289-93. PubMed ID: 7577484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative effects of calcitonin and clodronate in hypercalcaemia.
    Ljunghall S; Rastad J; Akerström G
    Bone; 1987; 8 Suppl 1():S79-83. PubMed ID: 2961359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of malignant hypercalcaemia with clodronate.
    Percival RC; Paterson AD; Yates AJ; Beard DJ; Douglas DL; Neal FE; Russell RG; Kanis JA
    Br J Cancer; 1985 May; 51(5):665-9. PubMed ID: 3158326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of skeletal disease in breast cancer with clodronate.
    Paterson AH; Ernst DS; Powles TJ; Ashley S; McCloskey EV; Kanis JA
    Bone; 1991; 12 Suppl 1():S25-30. PubMed ID: 1720012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of dichloromethylene diphosphonate in metastatic bone disease.
    Jung A; Chantraine A; Donath A; van Ouwenaller C; Turnill D; Mermillod B; Kitler ME
    N Engl J Med; 1983 Jun; 308(25):1499-501. PubMed ID: 6222257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone and renal components in hypercalcemia of malignancy and responses to a single infusion of clodronate.
    Bonjour JP; Philippe J; Guelpa G; Bisetti A; Rizzoli R; Jung A; Rosini S; Kanis JA
    Bone; 1988; 9(3):123-30. PubMed ID: 2971382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clodronate in the medical management of hyperparathyroidism.
    Hamdy NA; Gray RE; McCloskey E; Galloway J; Rattenbury JM; Brown CB; Kanis JA
    Bone; 1987; 8 Suppl 1():S69-77. PubMed ID: 2961358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of dichloromethylene diphosphonate in Paget's disease of bone and in hypercalcaemia due to primary hyperparathyroidism or malignant disease.
    Douglas DL; Duckworth T; Russell RG; Kanis JA; Preston CJ; Preston FE; Prenton MA; Woodhead JS
    Lancet; 1980 May; 1(8177):1043-7. PubMed ID: 6103389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clodronate treatment in patients with malignancy-associated hypercalcemia.
    Rastad J; Benson L; Johansson H; Knuutila M; Pettersson B; Wallfelt C; Akerström G; Ljunghall S
    Acta Med Scand; 1987; 221(5):489-94. PubMed ID: 2955674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.